An intervention to improve hydroxyurea adherence may improve quality of life in teens with SCD, according to an analysis of ...

Correctsequence's experimental gene-editing therapy CS-101 has been used to treat a person with SCD for the first time.

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, is highlighting the recent European Heart Journal publication of SCD-PROTECT, an independent clinical ...

Parents' childhood trauma may shape emergency care use patterns in their children with sickle cell disease, a study finds.